Today's highlights: 25 August 2010
This article was originally published in Scrip
Executive Summary
FDA hands refusal to file letter to EpiCept for lead leukaemia product
Strike date set in AstraZeneca UK pension dispute
Extended review for Acetadote supplement hits Cumberland shares
Pipeline progress at Oxford BioMedica as H1 losses reach £2.9 million
Baxter acquires alpha 1-antitrypsin therapy and technology from Kamada
Pfizer gets WHO approval for pneumocococal vaccine
Indian govt paper to reignite debate on compulsory licensing
First Phase III results for perampanel in epilepsy look positive